This study implies that circRNF13 mediates glycolysis in NPC by binding to SUMO2 and provides an important theoretical basis for further elucidating the pathogenesis of NPC and targeted therapy. The gene discussed is SUMO2; the disease is nasopharyngeal carcinoma.